Patent and Trademark
More on Patent and Trademark
Sudden and sharp increases in the cost of life-saving prescription medications have caused much public outcry, most recently regarding the substantial spike in the price of EpiPen, which is used to treat life-threatening allergic reactions.
Although today's hearing focuses on competition in the markets for a particular set of life-saving drugs -- namely, those that treat opioid addiction -- I hope that there are some broader lessons that we can draw from our discussion today.
TUESDAY, SEPTEMBER 13
11:00 a.m. Subcommittee on the Constitution and Civil Justice
Hearing on: Exploring Federal Diversity Jurisdiction
Witnesses:
- Mr. Charles Cooper, Partner, Cooper & Kirk, PLLC
- Ms. Joanna Shepherd, Professor of Law, Emory Law School
- Mr. Ronald Weich, Professor of Law, University of Baltimore
2237 Rayburn House Office Building
1:00 p.m. Subcommittee on Courts, Intellectual Property, and the Internet
House Judiciary Committee Ranking Member John Conyers, Jr. (D-MI) joined U.S. Representatives Jerrold Nadler (D-NY), Marsha Blackburn (R-TN) and Darrell Issa (R-CA) as well as legendary Four Tops founding member, Duke Fakir, T Bone Burnett, Roseanne Cash, and more than three dozen artists and musicians at a press conference in support of H.R. 1733, the Fair Play Fair Pay Act. The legislation would harmonize and modernize the outdated rules that currently govern music licensing for digital and terrestrial radio broadcasts.
Today's hearing gives us an opportunity to study how the International Trade Commission handles patent disputes and whether it sufficiently protects American innovation.
In particular, we should focus on whether the Commission produces fair results to litigants and, most importantly, whether these results are beneficial to the American consumer.
Congress established the Commission as an independent, quasi-judicial federal agency to provide non-partisan counsel to the legislative and executive branches of the government.
The House Judiciary Committee has announced its schedule for the week of April 11-15, 2016.
Today, U.S. Representatives John Conyers, Jr. (D-MI), Thomas Massie (R-KY), Bill Foster (D-Ill.), Paul Gosar (R-AZ), Scott Peters (D-Calif.) and Curt Clawson (R-FL) and U.S. Senators Chris Coons (D-Del.) and David Vitter (R-La.) held a joint press conference to highlight the broad opposition to sweeping anti-patent legislation moving through Congress.
Group of Senators and Representatives to Hold Bipartisan Press Conference to Highlight Broad Opposition to Sweeping Anti-Patent Legislation Moving Through Congress
H.R. 9 scheduled for July vote in the House
Today, House Judiciary Committee Ranking Member John Conyers, Jr. (MI-13) released the following statement after the House Judiciary Committee passed H.R. 9, the Innovation Act by a vote of 24-8: